Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2024)

Zhengye Biotechnology Holding (ZYBT) has disclosed Invested Capital for 2 consecutive years, with $50.1 million as the latest value for Q4 2024.

  • Quarterly Invested Capital rose 2.23% to $50.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $50.1 million through Dec 2024, up 2.23% year-over-year, with the annual reading at $50.1 million for FY2024, 0.31% changed from the prior year.
  • Invested Capital for Q4 2024 was $50.1 million at Zhengye Biotechnology Holding, up from $49.0 million in the prior quarter.
  • The five-year high for Invested Capital was $50.1 million in Q4 2024, with the low at $49.0 million in Q4 2023.